Edition:
United Kingdom

KemPharm Inc (KMPH.OQ)

KMPH.OQ on NASDAQ Stock Exchange Global Market

4.50USD
21 Sep 2018
Change (% chg)

$-0.17 (-3.74%)
Prev Close
$4.68
Open
$4.70
Day's High
$4.70
Day's Low
$4.30
Volume
26,783
Avg. Vol
15,110
52-wk High
$8.35
52-wk Low
$3.45

Chart for

About

KemPharm, Inc. is a clinical-stage specialty pharmaceutical company. The Company is engaged in the discovery and development of prodrugs. The Company uses its Ligand Activated Therapy (LAT) platform technology to create prodrugs. The Company's product candidate, KP201/APAP, consists of KP201, its prodrug of hydrocodone, which is... (more)

Overall

Beta: --
Market Cap(Mil.): $55.33
Shares Outstanding(Mil.): 14.66
Dividend: --
Yield (%): --

Financials

  KMPH.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -3.15 -- --
ROI: -57.85 1.79 14.61
ROE: -- 3.28 16.33

Earnings vs. Estimates